NCT01411111View on ClinicalTrials.gov

A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 6, 2011

Primary Completion Date

February 23, 2011

Study Completion Date

February 23, 2011

Conditions
Asthma
Interventions
DRUG

Rosuvastatin 10 mg

days 1-14

DRUG

GSK2190915 30mg

1x30mg tablet, days 8-14

DRUG

GSK2190915 100mg

1x100mg tablet, days 8-14

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01411111 - A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin | Biotech Hunter | Biotech Hunter